论文部分内容阅读
目的 :分析胆汁反流性胃炎的临床治疗效果。方法 :择取本院于2013年9月-2016年3月期间收治的胆汁反流性胃炎患者66例,通过随机双盲法,将患者划分为治疗组与参照组,每组各33例。对参照组患者行多潘立酮+埃索美拉唑酶肠溶片治疗,对治疗组患者行伊托必利+埃索美拉唑酶肠溶片治疗,对比两组患者的临床治疗效果。结果 :治疗组患者的临床治疗有效率为96.97%,参照组患者的临床治疗有效率为75.76%,两组数据对比,组间存在满足统计学意义要求的差异(P<0.05)。结论 :对胆汁反流性胃炎患者行伊托必利+埃索美拉唑镁肠溶片治疗,可以显著改善患者的临床症状,提高患者预后质量,有利于患者获取更好的生命质量与生活质量。
Objective: To analyze the clinical effect of bile reflux gastritis. Methods: Sixty-six patients with bile reflux gastritis were selected from September 2013 to March 2016 in our hospital. Patients were divided into treatment group and reference group by randomized double-blind method, with 33 cases in each group. Patients in the reference group were treated with domperidone plus esomeprazole enteric-coated tablets, and itoprazole plus esomeprazole enteric-coated tablets were given to the patients in the treatment group. The clinical effects were compared between the two groups. Results: The effective rate of clinical treatment was 96.97% in the treatment group and 75.76% in the reference group. The difference between the two groups was statistically significant (P <0.05). Conclusion: Itopride + esomeprazole magnesium enteric-coated tablets for patients with bile reflux gastritis can significantly improve the clinical symptoms, improve the prognosis of patients, and help patients to obtain better quality of life and life quality.